4.3 Article

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors

Journal

PANCREAS
Volume 49, Issue 7, Pages 863-881

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPA.0000000000001597

Keywords

pancreatic neuroendocrine tumor; islet cell tumors; pancreatic endocrine tumors; pancreatic neuroendocrine carcinoma; insulinoma; gastrinoma; glucagonoma; somatostatinoma; VIPoma; somatostatin analogs; octreotide; lanreotide; peptide receptor radionuclide therapy; PRRT; everolimus; sunitinib; capecitabine; temozolomide; NANETS; North American Neuroendocrine Tumor Society; guidelines

Ask authors/readers for more resources

This article is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The guidelines panel consisted of medical oncologists, pathologists, gastroenterologists, endocrinologists, and radiologists. The panel reviewed a series of questions regarding the medical management of patients with pancreatic neuroendocrine tumors as well as questions regarding surveillance after resection. The available literature was reviewed for each of the question and panel members voted on controversial topics, and the recommendations were included in a document circulated to all panel members for a final approval.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available